In osteoblasts only the type III Na + -dependent phosphate (NaPi) transporter isoforms Pit-1 and Pit-2 have been identified. We tested the effects of extracellular Pi, Ca 2+
Introduction
Phosphate (Pi) is essential for all living cells and plays a central role in bone mineralization where its local availability is a prerequisite for normal hydroxyapatite (crystal) formation. In this context, its facilitated transport across the kidney tubule is necessary to maintain adequate circulating Pi levels. Homeostasis of extracellular Pi is achieved primarily by its reabsorption in the proximal kidney tubule through the hormone-and phosphatesensitive type II Na + -dependent phosphate (NaPi) transporter (Tenenhouse 1997) . Inefficient Pi reabsorption by the kidney is associated with severe hypophosphatemia and defective mineralization of the skeleton, which manifests itself as rickets in children and in osteomalacia in adults (Beck et al. 1998 ).
The most recently described family of NaPi transporters (type III) was originally identified as retroviral receptors for gibbon ape leukemia virus Glvr-1 (O'Hara et al. 1990 ) and for rat amphotropic virus Ram-1 (O'Hara et al. 1990 , Miller et al. 1994 , Olah et al. 1994 , van Zeijl et al. 1994 . A slight sequence similarity with a putative phosphate permease from Neurospora crassa suggested that these membrane proteins might exhibit Pi transport activity (Kavanaugh et al. 1994) . Indeed, both receptors, human Glvr-1 and rat Ram-1, were found to mediate Pi transport in a Na + -dependent manner after expression in Xenopus laevis oocytes. Referring to the newly discovered functional characteristics of these viral receptors, Glvr-1 and Ram-1 were termed Pit-1 and Pit-2 respectively (Kavanaugh & Kabat 1996) . Pit-1 and Pit-2 belong to the SLC20 family of solute carriers (Collins et al. 2004) . Several features distinguish type III NaPi transporters from their more extensively studied type I and II counterparts. In contrast to the type I liver/kidney-and the type II kidney-specific NaPi transporters, Pit-1 and Pit-2 are widely expressed in mammalian tissues (Boyer et al. 1998 , Overbaugh et al. 2001 . Even though Pit-1 and Pit-2 exhibit Pi affinities of the same order of magnitude as the kidney-specific transporters, they display no obvious sequence similarity to the latter (Murer & Biber 1996 , Werner et al. 1998 . Pit-1 and Pit-2 play a fundamental housekeeping role in Pi transport, such as absorption of Pi from interstitial fluid to maintain normal cellular functions (metabolism, signal transduction, and nucleic acid and lipid synthesis), whereas type II transporters are responsible for transepithelial Pi reabsorption in the kidney (Murer & Biber 1996) . Another distinguishing feature is that type III transport is specifically blocked following infection with the appropriate virus. The loss of type III transportermediated Pi transport does not compromise the viability of the infected cell, suggesting that additional housekeeping Pi transporters may exist that are capable of compensating for the loss of Pit-1-and Pit-2-mediated Pi uptake (Kavanaugh et al. 1994) . In contrast, the loss of either type I or II Pi transporters in the kidney has severe metabolic consequences (Beck et al. 1998 , Tenenhouse et al. 1998 , Hoag et al. 1999 , Gupta et al. 2001 .
Insulin-like growth factor-I (IGF-I) has been shown to stimulate NaPi-II-mediated Pi transport in an opossum kidney cell line (Jehle et al. 1998) . Moreover, IGF-I increases Pit-1 mRNA expression and Pi uptake in a human osteosarcoma cell line (Palmer et al. 1997 . In contrast to the NaPi transporter kidney isoforms, NaPi transporter species expressed in bone have not been extensively studied. Therefore, apart from assessing tissue-specific and agedependent mRNA expression of NaPi isoforms in newborn and adult rats, we investigated their regulation by extracellular Pi deprivation and by Ca 2+ and IGF-I in bone-derived rat cells in vitro.
Our data show upregulation of Pit-1 (but not Pit-2) mRNA expression and enhanced Pi transport in osteoblastic cells in response to Pi depletion or following treatment with Ca 2+ or IGF-I.
Materials and Methods

Animals
All animal experiments were approved by the Institutional Animal Welfare Committee. Brain, calvarial bone, heart, lung, liver, kidney and intestine from newborn (1 day old) or adult male (150-160 g) rats (Wistar; Harlan, Horst, The Netherlands) were excised, blotted on filter paper, weighed, immediately frozen in liquid nitrogen and stored at 80 C until RNA was isolated.
Cell cultures
PyMS osteoblast-like cells were kindly provided by Dr A Lichtler (University of Connecticut) (Veldman et al. 1997 . The cells were passaged in tissue culture flasks (Falcon, Meyland Cedéx, France) in Dulbecco's modified Eagle's medium (DMEM) supplemented with gentamicin (50 µg/ml), glutamine (2 mmol/l), and fetal calf serum (FCS; 5%; all from Gibco) at 37 C in an atmosphere of 5% CO 2 in air. Cell cultures between passages 8 and 23 were used.
Calvaria of newborn rats were sequentially digested with bacterial collagenase (type CLS II, Worthington, Freehold, NJ, USA) in PBS and the released cells were grown as described previously (Veldman et al. 1997) .
Both cell types were grown to confluence and detached from the dishes with 0·25% trypsin (Gibco) and replated in multiwell tissue culture plates (Falcon, 35 mm diameter) at a density of 2 10 5 cells/well. Confluent monolayer cultures were used 4 days after seeding. Twenty-four hours before studying Pi transport and Pi transporter mRNA expression, cells were rinsed with serum-free medium, and the growth medium was replaced by serumfree F-12 medium containing gentamicin (50 µg/ml), glutamine (2 mmol/l) and charcoal-treated BSA (Serva, Heidelberg, Germany) at 1 g/l. For the Pi deprivation studies, Pi-free DMEM medium ([Ca 2+ ] 1·8 mM) was used instead of F-12; for the Ca 2+ -treatment experiments, F-12 medium ([Pi] 1 mM, [Ca 2+ ] 0·3 mM) was used. Aliquots of test agents (NaH 2 PO 4 (1 mM), recombinant human (rh) IGF-I (1 nM; Ciba-Geigy, Basel, Switzerland), CaCl 2. and phosphonoformic acid (PFA; foscarnet 0·5 mM, a blocker of Pi transport through the plasma membrane; Sigma) were added directly to the media. Cells were incubated as specified in the Results.
For RNA analysis, cells were plated at a density of 10 6 cells/10 cm diameter dish (Falcon) in DMEM containing 5% FCS. Confluent monolayer cultures were used 4 days after seeding. Cells were rinsed with serum-free medium and exposed to test media ( Pi, 1 nM IGF-I, 0·25 or 1 mM additional CaCl 2 ) for 24 h as described above, then rinsed with ice-cold PBS and lysed in ice-cold 4 M guanidine isothiocyanate containing 5 mM sodium citrate (pH 7·0), 0·1 M -mercaptoethanol and 0·5% sarcosine.
RNA isolation
Calvarial bones were quickly removed and placed in Petri dishes containing SET solution (1% SDS, 5 mM EDTA, 10 mM Tris, pH 7·5). They were cleaned of adherent tissue including the periosteum, and the edges were cut (Zoidis et al. 2000) . The pieces of bone and the other frozen tissues (0·5-1 g) were homogenized in a Polytron homogenizer (Brinkmann Instruments, Westbury, NY, USA) in 3 ml ice-cold 4 M guanidine isothiocyanate containing 5 mM sodium citrate (pH 7·0), 0·1 M -mercaptoethanol and 0·5% sarcosine. The homogenates were centrifuged at 500 g for 5 min at 4 C and filtered through a Millex-HA filter unit (0·45 µm pore size, Millipore, Bedford, MA, USA) (Zoidis et al. 2000) .
Total RNA from bone, osteoblast-like cells (as described above) and all examined tissues was obtained by high-speed sedimentation through a cesium chloride cushion. Concentrations were determined spectrophotometrically (1 OD 260 nm =40 mg/ml RNA), and stored at 80 C until assayed (Zoidis et al. 2002) .
Northern-blot analysis
Denatured total RNA (20 µg) from tissues and cells was electrophoresed on a 1% agarose gel (stained with ethidium bromide) containing 2 M formaldehyde, transferred onto a nylon membrane (Hybond-N, Amersham) by capillary blotting, and fixed by u.v. cross-linking according to standard procedures (Sambrook et al. 1989) . Prehybridization and hybridization were carried out at 42 C in a hybridization incubator (Appligene Inc., CA, USA). Membranes were prehybridized in a solution containing 50% (v/v) deionized formamide, 5 Denhardt's solution (0·02% (w/v) Ficoll and 0·02% (w/v) polyvinyl pyrrolidone), 5 SSPE (20 =3·6 M NaCl, 0·2 M sodium phosphate, 0·02 M EDTA, pH 7·7), 0·2% SDS and 100 µg/ml heat-denatured salmon sperm DNA. Hybridizations were performed in the same solution with 20-25 ng (2 10 7 c.p.m.) labeled cDNA/ membrane.The following cDNAs (made by reverse transcription (RT)-PCR in our laboratory) were used for hybridization (Table 1) : rat type I sodium-dependent (Na d ) phosphate (Pi) transporter (NaPi-I) cDNA (nucleotide 578-1004, GenBank accession no. U28504); rat brain-specific NaPi-I (BNPI) cDNA (nucleotide 302-1647, GenBank accession no. U07609); rat NaPi-IIa cDNA (nucleotide 366-1202, GenBank accession no. L13257) (Magagnin et al. 1993 ) rat NaPi-IIb cDNA (nucleotide 624-1421, GenBank accession no. AF157026) (Hashimoto et al. 2000) ; three distinct rat Pit-1 cDNAs (nucleotides 133-1431, 133-450 and 2114-2483, GenBank accession nos AB000489 and L20852); rat Pit-2 cDNA (nucleotide 935-1646, GenBank accession no. L19931). The cDNA probes were labeled by random primer extension using a commercial kit (Boehringer Mannheim) and [ -32 P]deoxy-CTP (3000 Ci/mmol; Amersham) to specific activities of 2-4 10 9 c.p.m./µg DNA. After 48 h of incubation at 42 C, the membranes were washed twice for 15 min at room temperature in 2 SSPE-0·1% SDS and then twice for 10 min in 0·1% SSC-0·1% SDS at 49-55 C. Membranes were then exposed at 80 C to an X-Omat AR-5 film (Kodak, Rochester, NY, USA) in cassettes equipped with intensifying screens to visualize 32 P-labeled cDNA-mRNA hybrids. mRNA levels were quantitated by scanning densitometry using a BioRad video densitometer. Variations of gel loading were corrected against 18S ribosomal RNA values.
Transport studies
Confluent PyMS cells were kept in Pi-free or 1 mM Pi-containing, serum-free medium for 24 h before determination of the initial rate of Pi uptake (initiated by adding 1 ml of transport buffer, containing 32 PO 4 ) in buffer containing 0·02-10 mM KH 2 PO 4. Except for the kinetic data presented in Table 2 , transport studies were conducted at Pi concentrations of 1 mM, i.e. a Pi concentration close to the physiological extracellular Pi concentration. Before the start of the experiments, monolayers were washed (and left for 20 min) at room temperature with 1 ml transport buffer A or B containing (in mmol/l): 140 NaCl or choline chloride, 5 KCl, 1 MgCl 2 , 1·5 CaCl 2 , 15 N-2-hydroxy-ethylpiperazine-N'-2-ethanesulfonic acid The indicated numbers refer to the nucleotide position within the respective sequence where the 5 end of the primer will anneal. Species from which the primers were designed. f, forward; r, reverse.
(HEPES), adjusted to pH 7·4 with Tris-(hydroxymethyl)aminomethane HCl. Transport buffer B containing choline chloride instead of NaCl was used for measuring Na + -independent Pi uptake. The 32 Pi-uptake studies were performed at room temperature and initiated by adding 1 ml transport buffer, containing 0·1 mmol/l KH 2 32 PO 4 (1 µCi/ml; 200 mCi/mmol; Amersham). Transport buffer contained, in addition, unlabeled KH 2 PO 4 as indicated in the Results; 10 min later the buffer was removed, and the dishes were quickly rinsed three times with 1 ml ice-cold transport buffer. The cells were then solubilized with 1 ml of 2% SDS, and the radioactivity of a 0·5 ml aliquot was counted in a liquid scintillation counter (Betamatic, Kontron Instruments AG, Zurich, Switzerland).
Determination of protein content and alkaline phosphatase activity
After 4 days of culture, including 24 h in test medium as described above, cells were lysed from dishes into 2 ml of 0·1% Triton X-100 for the determination of protein content by the bicinchoninic acid (BCA) method (Smith et al. 1985) and of alkaline phosphatase activity by measuring the cleavage of p-nitrophenyl phosphate to p-nitrophenol at pH 10·2 using the Sigma Fast kit .
[ 3 H]thymidine incorporation into DNA
Cells were plated and grown as above, but exposed to DMEM (containing 3 µM thymidine, different Pi concentrations and/or PFA as indicated) for 18 h, then pulsed with methyl-[ 3 H]thymidine (Amersham; 80 Ci/mmol; 1 µCi/dish) for 3 h at 37 C, rinsed with cold PBS, and DNA was precipitated and washed three times in situ with 10% trichloroacetic acid; incorporated radioactivity was measured in a liquid scintillation counter.
Statistical analysis
Results are expressed as means S.E.M. or S.D. as indicated, and are representative of at least three independent experiments. Statistical analysis was performed by Student's t-test or ANOVA, with P,0·05 considered statistically significant.
Results
Age-dependent and tissue-specific Pit-1 and Pit-2 mRNA expression
Northern-blot analysis showed a wide but distinct tissue distribution of Pit-1 (4·3 kb) and Pit-2 (4·1 kb) mRNA (Figs 1 and 2 ). Pit-1 mRNA expression was highest in newborn brain followed by newborn heart, lung, calvaria and kidney (Fig. 1) . Only in the intestine was Pit-1 mRNA expression higher in adult than in newborn rats (Fig. 1) . Pit-2 mRNA expression was also higher in newborn than in adult animals ( Fig. 2) and was most prominent in the heart. In contrast to Pit-1, Pit-2 mRNA expression was low in newborn and adult intestine. Adult liver showed 2-fold higher expression than newborn liver (Fig. 2) .
We also performed hybridization analysis with rat cDNA probes (cDNA primer sequences and annealing position shown in Table 1 ) for the NaPi-I (specific for liver-kidney), NaPi-II (a, specific for kidney; b, specific for gut-lung) and for the rat BNPI isoforms. While specific transcripts of the expected size were detected in the corresponding tissues (1·8 and 2·3 kb NaPi-I transcripts in liver and kidney, 2·7 kb NaPi-II transcripts in kidney 4·4 kb NaPi-IIa transcripts in lung and intestine, and 2·8 kb BNPI transcripts in brain), none of these transcripts were detected in bone and osteoblastic cells (not shown). An additional 6 kb transcript of Pit-1 was found in calvarial bones of newborn animals (Fig. 1, lower panel) . After longer exposure (7-10 days), this transcript was also detectable in the lung of newborn rats and in PyMS cells. However, our attempts to obtain the full-length transcript (consistently detected with three different cDNA probes: nucleotides 133-1431, 133-450 and 2114-2483; see primer sequences and annealing position in Table 1 ) by using rapid amplification of cDNA ends (RACE) and a variety of 5 -and 3 -end primers (Table 1) were unsuccessful.
Effects of Pi deprivation and increased Pi concentrations on protein levels, alkaline phosphatase activity, [ 3 H]thymidine incorporation, Na d Pi transport and kinetic parameters
Pi deprivation for 24 h in serum-free medium did not affect protein content, alkaline phosphatase activity and [ 3 H]thymidine incorporation rates of PyMS cells (Table 2) , suggesting no detrimental effects on cell viability under these conditions, i.e. when the proliferation rate of these cells is low. Table 2 , Na d Pi transport was significantly decreased when 1 mM Pi was added to the Pi-free medium for the last 24 h of culture, reflecting an increase in Na d Pi transport when cells are switched to and kept in Pi-free medium for the last 24 h of culture ( Table 2) .
As illustrated in
The kinetic parameters of the Na d Pi transport system were obtained by Lineweaver-Burk analysis from experiments where Pi transport was studied over a range of Pi concentrations from 0·02 to 10 mM (not shown). Data from five pairs of curves are combined in Table 2 for calculation of the apparent affinity constant (K M ) and maximal transport rate (v max ). The stimulatory effect of Pi depletion was due to an increase in v max from 1·83 0·17 to 2·47 0·20 nmol Pi/mg protein 10 min (P,0·05) without a significant change in the apparent K M for Pi (109 12 vs 117 9 µmol/l) ( Table 2) . 32 Pi uptake in cells kept for 24 h at 5 or 10 mM Pi was even higher in choline-than in sodium-containing buffer (not shown) and, thus, was no longer Na + -dependent probably due to leakage of damaged cell membranes. In contrast to Pi deprivation, 5 and 10 mM Pi resulted in a large number of detached cells and was obviously toxic. Consistent with the toxic effect of high Pi, protein content per dish was decreased and thymidine incorporation into DNA was nearly abolished. This was prevented by incubation with 0·5 mM PFA, a specific competitive and reversible inhibitor of Na d Pi transport (not shown).
Effects of Pi deprivation, and of IGF-I and Ca 2+ on Pit-1 mRNA expression in PyMS cells
PyMS cells express Pit-1 transcripts of the expected size of 4·3 kb (Fig. 3, lower panel) . Quantitative evaluation of the 4·3 kb Pit-1 mRNA levels showed decreased Pit-1 mRNA when Pi concentration was increased (as compared with the Pi-free control). The experiments reflect an increase in Pit-1 mRNA levels after Pi withdrawal by a mean of 40 and 70% (P,0·05) relative to the expression in cells kept at 0·5 and 1 mM Pi respectively (Fig. 3, upper  panel, black columns) .
IGF-I (1 nM) stimulated Pit-1 mRNA expression to a higher extent in Pi-free media than in media containing 1 mM Pi. Pit-2 mRNA expression levels were not affected (not shown). Stimulation of Pit-1 mRNA expression by IGF-I was 1·65 0·2, 1·8. 0·2 and 1·3 0·1-fold at 0, 0·5 and 1 mM Pi (Fig. 3, upper panel, gray columns) as compared with the corresponding IGF-I-free media (black columns).
Increasing the Ca 2+ concentration by 1 mM to a final concentration of 1·3 mM stimulated Pit-1 (Fig. 4) (Veldman et al. 1997 . IGF-I (10 nM) also stimulated the expression of Pit-1 mRNA in calvarial cells (Fig. 5) .
Discussion
In this study we demonstrate age-dependent and tissuespecific expression of Pit-1 and Pit-2 (type III NaPi) mRNA and upregulation of Pit-1 but not Pit-2 mRNA expression by Pi depletion, or by treatment with Ca 2+ or IGF-I. The non-malignant rat cell line PyMS was used since these osteoblastic cells have been well characterized regarding IGF-I-and Ca 2+ -stimulated Pi transport (Veldman et al. 1997 . For all tissues examined, except intestine, NaPi-III mRNA levels were higher in newborn than in adult rats. This is consistent with increased Pi requirement in the rapidly growing organism and suggests a role of type III Na + -dependent Pi transporters in Pi retention during this highly anabolic phase. In contrast to humans, rats keep growing throughout life, their epiphyses remain open, and their serum phosphate remains high after sexual maturation. In adult rats, Pit-1 mRNA expression is most abundant in tissues rich in highly polarized epithelial cells (intestine and lungs) which also express NaPi IIb (Hilfiker et al. 1998 , Feild et al. 1999 , Xu et al. 1999 , Hashimoto et al. 2000 . In contrast, Pit-2 mRNA expression is highest in heart, which has a high Pi requirement for energy metabolism. Kavanaugh et al. (1994) also demonstrated a wide tissue distribution of Pit-1 (with highest mRNA levels in bone marrow) and Pit-2 (with highest mRNA levels in heart), consistent with their roles in mediating bloodborne targeting of viral infections to multiple tissues, but in their study neither bone nor osteoblasts were examined.
Investigations by Jono et al. (2000) in human aortic smooth muscle cells pointed to a role of Pit-1 in mediating matrix mineralization. This is also in line with the findings of Nielsen et al. (2001) that during differentiation of mouse osteoblastic MC3T3-E1 cells, which is accompanied by increased mineralization, Pit-1 is higher than Pit-2 mRNA expression. Nevertheless, bone and osteoblastic cells do not express Pit-1 and Pit-2 at higher levels than other tissues and cell types. Pit-1 mRNA has also been identified in human osteosarcoma cells (Chien et al. 1997 , Palmer et al. 1997 . Kinetic analysis of Pi transport revealed a rather high K M of 454 µmol/l in the osteosarcoma cell study by Palmer et al. (1997) and a K M of 137 µmol/l in the study by , i.e. a value which is close to that found in the current study for PyMS cells (Table 2) . The K M for Pi in PyMS cells (109 µmol/l) is close to the K M reported for fibroblasts, 133 µmol/l (O'Hara et al. 1990) , but higher than the K M for Pi when human Pit-1 is expressed in Xenopus oocytes, 24·1 µmol/l (Kavanaugh et al. 1994) . Pit-1 appears to be expressed at high levels also by most tumor cells and may therefore serve to cover the particular requirement for rapid growth, as also described for glucose transporter (GLUT)-1 mediated glucose uptake. In an in situ hybridization study in mice, Palmer et al. (1999) found Pit-1 transcripts in chondrocytes but failed to identify Pit-1 transcripts in osteoblasts.
The occurrence of a 6 kb Pit-1-related transcript in bone and osteoblastic cells, which is absent in fibroblasts (these express only the 4·3 kb transcript), may point to a novel 'bone-specific' Pi transporter-related mRNA. Unfortunately, we could not obtain full-length products of the observed transcript size in our RACE experiments. Therefore, we do not know whether the 6 kb transcript represents an alternative splice variant or an unspliced precursor RNA, but it may be of interest to note that the age dependence and the restriction of the 6 kb transcript expression to bone and lung resembles that of Phex, an enzyme which plays an important role in the regulation of extracellular Pi (HYP Consortium 1995 , Tenenhouse 1999 , Drezner 2000 . Increased Na d Pi transport due to Pi deprivation was accompanied by increased Pit-1 (but not Pit-2) mRNA levels; this is in line with findings by Chien et al. (1997) in two human osteosarcoma cell lines. Obviously, Pi deprivation used for in vitro studies is not a physiological condition, and its in vivo significance is unclear. In the artificial setting of cultured cells, the Pi requirement may be different from that in osteoblasts in vivo. Moreover, there is no circulating Pi supplying extracellular milieu, and the contact time with the extracellular medium is markedly prolonged in the cultured cells. However, it is of note that our cells remained viable after the 24 h exposure to Pi-free medium as apparent from unchanged DNA synthesis, protein content and alkaline phosphatase activity. Pi uptake in the absence of extracellular Na + was unaffected, suggesting that the change in Na d Pi uptake cannot be accounted for by a non-specific increase in Pi diffusion. Enhanced Na d Pi transport was due to an increase in the apparent v max with no change in the apparent K M for Pi. Raising the extracellular Pi Figure 4 Pit-1 mRNA expression in PyMS cells after 24 h treatment with CaCl 2 . Cells were incubated in F-12 medium (containing 0·3 mM calcium, control) to which 0·25 and 1 mM calcium were added to yield final concentrations of 0·55 and 1·3 mM respectively. Upper panel: 20 g total RNA was processed as described in Fig. 1 concentration to 5 and 10 mM induced cell death; this was prevented by incubation with 0·5 mM PFA (not shown), in agreement with observations in osteoblast-like cells isolated from human bone (Meleti et al. 2000) .
Higher Pit-1 mRNA levels after Pi withdrawal were observed irrespective of additional treatment with IGF-I. This anabolic hormone stimulates Pi uptake rapidly in osteoblasts by increasing v max (Veldman et al. 1997) . The acute component of this stimulation is blocked by colchicine but not by actinomycin and cycloheximide (Campbell et al. 1992 , Veldman & Schmid 1996 . Longer-term stimulation of Na d Pi transport by IGF-I may be attributed to an increase in Pit-1 mRNA as also reported for osteosarcoma cells (Palmer et al. 1997, Zoidis et al. unpublished observations) . Similar to IGF-I, increasing extracellular Ca 2+ concentrations (starting from a basal medium with a low calcium concentration, lower than usually met in vivo) stimulated Pit-1 but not Pit-2 mRNA levels. Since Pit-1 expression was highest at the high (more physiological) Ca 2+ concentration, one could also argue that lowering Ca 2+ decreases Pit-1 expression. IGF-I not only increases Na d Pi transport (Veldman et al. 1997) , but also Pit-1 mRNA (Fig. 5) in 'normal' primary rat calvarial osteoblasts although these cells are less responsive to exogenous IGF-I, due to auto-/ paracrine IGF-I production (Veldman et al. 1997 . Many active Pi transporters including some that have no role in transcellular Pi movement are found in several types of animal cells (Wehrle & Pedersen 1989) . The tissue-specific Pi handling by osteoblasts is determined by the high Pi requirement of skeletal tissue at the time of mineralization. Pit-1 may well serve this function. Thus far, there is no evidence for an additional osteoblastrestricted NaPi isoform. IGF-I stimulates growth together with Phex and osteocalcin mRNA expression in calvarial bones of hypophysectomized rats (Zoidis et al. 2002) at a time when net transfer from gut to bone is increased, but serum Pi and renal NaPi-II mRNA expression remain unaffected. Therefore, we performed preliminary RT-PCR analysis of RNA samples isolated from calvarial bone of the vehicle-and the IGF-I-treated hypophysectomized rats of the study of Zoidis et al. (2002) . We found that IGF-I treatment resulted in a 5-fold increase of relative Pit-1 mRNA expression (not shown). In conclusion, our data show regulation of Pit-1 expression in bone and suggest that Pit-1 is a candidate transporter of physiological relevance in bone.
